Skip to main content

Table 1 Baseline characteristics

From: Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline

 

No Diabetes (n = 2310)

Diabetes (n = 994)

P value for respective effect

     

DM

EF

 

EF <50% (n = 1769)

EF ≥ 50% (n = 541)

EF <50% (n = 824)

EF ≥ 50% (n = 170)

  

Female (%)

23.5

49.2

28.9

51.2

0.005

<0.001

Age (years)

61.1 ± 14.3

63.1 ± 14.0

67.2 ± 10.3

69.4 ± 7.6

<0.001

<0.001

Body mass index (kg/m2)

26.9 ± 4.5

28.5 ± 5.1

29.1 ± 5.5

30.3 ± 5.3

<0.001

<0.001

Heart rate (bpm)

73.0 ± 13.5

69.7 ± 12.7

74.2 ± 12.5

72.4 ± 14.4

0.004

<0.001

Systolic blood pressure (mmHg)

121 ± 19

138 ± 23

125 ± 19

140 ± 21

<0.001

<0.001

Diastolic blood pressure (mmHg)

73 ± 11

79 ± 12

73 ± 11

77 ± 13

0.076

<0.001

Glomerular filtration rate (mL/min)

72 ± 24

75 ± 22

64 ± 26

68 ± 24

<0.001

0.002

Hb (mmol/mL)

8.7 ± 1.1

8.7 ± 1.0

8.4 ± 1.2

8.3 ± 1.1

<0.001

0.644

SF-36 score

52 ± 28

59 ± 28

44 ± 28

44 ± 27

<0.001

0.020*

  1. * Significant interaction (p = 0.015) between diabetes and ejection fraction
  2. • DM: Diabetes mellitus, EF: ejection fraction